Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for interleukin 2
Most Correlated Studies
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- CD8+ T cells activated by antigen; effects of gamma-cytokine treatment
Most Relevant Literature
- IL-2 based cancer immunotherapies: an evolving paradigm.
- Interleukin-2-based therapies in cancer.
- The soluble IL-2 receptor α/CD25 as a modulator of IL-2 function.
- Insights into the binding recognition and computational design of IL-2 muteins with enhanced predict…
- Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer.
Most Relevant Clinical Trials
- HIV Reservoir Reduction With Interleukin-2
- Efficacy of Low-dose Interleukin-2 Treatment in Chronic Spontaneous Urticaria
- Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy
- Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica
- Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma
